CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-15). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2648 · Search date 2026-08-15 · Methodology v0.7

Desktop humidifier,
does it really help with Longer noninvasive tear-film breakup time after one hour of screen work?

30-Second Summary
C
Evidence Grade C · 50 · Safety acceptable
A short-term tear-film test improved, but durable dry-eye treatment was not established
No adverse events were observed during or after the one-hour procedure in 31 participants. The reservoir and mist outlet should still be cleaned according to manufacturer instructions.
What the
research shows
The grade is C with 50 points. In a 31-person trial, first noninvasive breakup time immediately after one hour of screen work was 9.65±2.55 seconds with humidification versus 6.20±2.45 without, and 8.13±3.10 versus 5.41±1.91 at 1.5 hours. The contrast was large, but this was a surrogate test from one tiny manufacturer-funded study whose registration became public the day after manuscript submission.
What the
ads claim
The finding does not establish equivalent effects for all mini humidifiers. It tested one EYE MOIST model, 31 participants, and a short laboratory measure, not long-term symptoms, corneal injury, or work performance.
*

Useful facts when choosing a product

  • The tested product was the Kaltech EYE MOIST photocatalytic micro-mist humidifier.
  • Relative humidity near the face changed by +22.6±3.5% with mist and -1.5±2.8% without mist.
  • No adverse events were observed during or after the procedure.
Gap Measurement · Verdict 2648 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2024 RCT by Arita R and Fukuoka S assigned 31 participants to mist on, n=15, or mist off, n=16, during one hour of VDT work and analyzed all participants. First breakup time was 9.65±2.55 versus 6.20±2.45 seconds immediately, P=.001, and 8.13±3.10 versus 5.41±1.91 at 1.5 hours, P=.025. Relative humidity around the face changed by +22.6±3.5% versus -1.5±2.8%. The paper's statistical-analysis section calls NIBUT-first primary, but its status in the protocol at registration was not verified. Kaltech funded the study. The conflict statement says, "R.A. was a consultant for Kaltech Corporation. S.F. received an honorarium from Kaltech Corporation."

02

Why this is classified as C (50)

Large short-term surrogate differences were limited by a 31-person manufacturer-only trial and post hoc public registration, giving C with 50 points.

Counterpoint. Immediate symptoms improved, but the 1.5-hour symptom contrast was null and no durable clinical outcome was measured.

Rejudgment record. Cross-check applied — Cross-checked analyzed sample, NIBUT-first values, local humidity, funding, conflicts, adverse events, and registration timing against the PMC paper and UMIN record

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI0Evidence comes only from manufacturer studies
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Longer NIBUT-first after one hour of VDT workCLarge contrasts were present immediately and at 1.5 hours in one small manufacturer trial.
Durable improvement in dry-eye symptoms?Long-term symptom outcomes were not measured.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Arita R, Fukuoka S. 2024Envelope-allocated randomized trial of mist on versus off; registry disclosure followed manuscript submission, and the primary outcome in the protocol at registration was not verified16Funded by Kaltech Corporation; conflict statement: "R.A. was a consultant for Kaltech Corporation. S.F. received an honorarium from Kaltech Corporation."NIBUT-first identified as primary in the paper's statistical-analysis section; secondary NIBUT-average and symptomsNIBUT-first 9.65±2.55 versus 6.20±2.45 seconds immediately, P=.001; 8.13±3.10 versus 5.41±1.91 at 1.5 hours, P=.025Only direct small manufacturer-funded surrogate trial
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-15).

Arita R, Fukuoka S. Safety and Efficacy of Photocatalytic Micro-Mist Desktop Humidifier for Dry Eye Caused by Digital Environment: A Randomized Controlled Trial. J Clin Med. 2024;13(13):3720. PMID: 38999288. DOI: 10.3390/jcm13133720. UMIN000054379.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-15 · Corrections: none

Cite this verdict

Desktop humidifier x tear-film stability during screen work Evidence Grade C card
[Chamgap] Desktop humidifier x tear-film stability during screen work — Evidence Grade C·50. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/eye/photocatalytic-desktop-humidifier-vdt-tear-film-breakup-time/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.